PMCF Retrospective Study Outcomes of a Monofocal Toric Intraocular Lens
NCT ID: NCT05055076
Last Updated: 2022-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
105 participants
OBSERVATIONAL
2021-08-01
2021-12-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigational device is CE approved. The investigational device and all study products, including the devices used for the study examinations, have been used within the intended use specifications from the manufacturer. In addition, there were no invasive or other burdening examinations.
The investigator is an accredited and experienced cataract surgeon and researcher.
The primary endpoint is to determine rotational stability in a minimum of 120 eyes of patients with PODEYE TORIC IOL implantation after cataract surgery. Patients will be enrolled for the documentation and evaluation of retrospective data up to 6 months postoperatively.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Europe (PHY2104)
NCT04987216
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Spain
NCT04866719
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
NCT04778501
PMCF Study on Monofocal Toric IOL (PODEYE TORIC)
NCT04744467
Clinical Investigation of a Monofocal Toric Intra Ocular Lens (IOL) in Cataractous Eyes
NCT05255029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
On patients with a low amount of pre-existing corneal astigmatism (defect in the sphericity of the cornea with a focal point depending on the meridian), the implantation of a spherical monofocal IOL is the state- of- the-art when targeting a good correction of distance visual function. However, in case of pre-existing corneal astigmatism, the implantation of spherical IOLs might not be the best solution, as such lenses only correct for spherical errors and leave the astigmatism uncorrected.
Toric IOLs are obtained by adding a cylinder power to the basis optic of a given spherical power, thus correcting for both spherical and cylindrical refractive errors. Toric IOLs provide the opportunity to reduce or eliminate astigmatism, thus offering patients with pre-existing astigmatism the possibility of restoring their distance vision with reduced or no need for the use of spectacles or contact lenses with a cylindrical correction. Not correcting the astigmatism component at the time of cataract surgery is an important cause for not obtaining planned emmetropia following IOL implantation. A previous study found that more than 22% of patients undergoing cataract surgery have substantial corneal astigmatism superior than 1.25 D and would benefit from toric IOL implantation 1).
This study will add to the knowledge on toric IOLs and help improve the care of patients and the outcomes of cataract surgery after toric IOL implantation.
The study is a monocentric, retrospective study to investigate rotational stability and visual performance after mono- or bilateral implantation of PODEYE TORIC intraocular lens following cataract surgery, executed only with standard of care examinations. The study outcomes will be used to confirm the safety performance for a stable IOL positioning of the investigation al device.
Preoperative, surgical and postoperative data (up to 6 months after surgery) will be collected retrospectively by reviewing the patient charts.
The investigational device PODEYE TORIC IOL is CE approved and commercially available in the country where this clinical investigation is being carried out. The investigational device and all study products, including the devices used for the study examinations, have been used within the intended use specifications from the manufacturer. In addition, no invasive or other burdening examinations will occur for the patient.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PODEYE TORIC
Adult patients who have undergone cataract surgery with mono- or bilateral implantation of POD EYE TORIC IOL (POD T 49P) and who meet all the inclusion and exclusion criteria will be invited to participate in the study.
PODEYE TORIC
Patients will be contacted consecutively and will be enrolled after the patient informed leaflet has been given to them and after obtaining their consent to the scientific use of their data collected retrospectively (preoperative, surgery, postoperative routine visits). Patients will only be enrolled after the routine 4-6 months visit has been performed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PODEYE TORIC
Patients will be contacted consecutively and will be enrolled after the patient informed leaflet has been given to them and after obtaining their consent to the scientific use of their data collected retrospectively (preoperative, surgery, postoperative routine visits). Patients will only be enrolled after the routine 4-6 months visit has been performed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capable of understanding the patient informed leaflet;
* Complete data available at the screening visit, surgical visit and at least one postoperative visit.
Exclusion Criteria
* Subjects who underwent previous intraocular or corneal surgery other than IO L implantation;
* Subjects in whom in-the-bag implantation was not possible;
* Subjects in whom surgical complications occurred (e.g. posterior rupture);
35 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beaver-Visitec International, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Beau Soleil
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHY2120
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.